Navigation Links
Mission Pharmacal Celebrates Historic Milestone
Date:2/2/2009

Pioneer in Women's Health Marks 64 Years of Innovation and Growth

SAN ANTONIO, Feb. 2 /PRNewswire/ -- Mission Pharmacal Company this year celebrates 64 years of excellence in manufacturing and distributing pharmaceutical products primarily for women's health. For more than six decades, Mission Pharmacal has enhanced the quality of consumers' lives through innovative, science-based, quality pharmaceutical products, vitamins and supplements.

Founded in 1945 by H.N. Walsdorf, a pharmacist, the Texas-based company was built on the philosophy that most existing pharmaceutical formulations had the potential to be more effective and better tolerated. Three generations later, Neill B. Walsdorf, Jr. carries on the traditions of quality and value established by his grandfather and continued by his father.

"We are honored to celebrate 64 years in the pharmaceutical industry," said Neill Walsdorf, Jr., president of Mission Pharmacal. "We recognize this achievement and will continue my grandfather's mission to provide breakthrough products and the level of quality that has been associated with the Mission name. In addition to our expertise in current therapeutic areas, we will look to developments in new areas of osteoporosis, urolithiasis and cardiovascular disease."

The company has a broad portfolio of over-the-counter and prescription products that enhance prenatal nutrition, treat parasitic and bacterial infections, prevent kidney stone recurrence and help relieve arthritis and muscle pain. Major brands include the CitraNatal(R) family of prescription prenatal vitamins, designed to support pregnant women's comfort with calcium citrate and other well-tolerated ingredients while optimizing nutrition for their babies' growth and development; Ferralet(R) 90, for iron deficiency anemia, that transforms prescription oral iron therapy into a gentle experience with carbonyl iron; Tindamax(R) (tinidazole), the only oral antimicrobial approved for the treatment of both trichomoniasis and bacterial vaginosis (as well as many other bacterial infections) and Urocit-K(R), a formulation of potassium citrate used to treat nephrolithiasis in people with kidney stones that is the standard treatment in its category.

About Mission Pharmacal Company

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas. For more than 60 years, Mission has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them. Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products. For more information on Mission, visit www.missionpharmacal.com.


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
2. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
3. Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission
4. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
5. Fairview Baptist Home Selects PatientPlacement.com to Automate Referrals and Increase Patient and Resident Admissions
6. EliteMeetings.com Announces Commission-Free Policy Comprehensive Search and RFP Engine Now Provides Net Rates for Groups
7. In Time, Cream Might Prevent Herpes Transmission
8. Pennsylvania Insurance Commissioner Welcomes U.S. House Vote to Reauthorize Childrens Health Care
9. One Mans Determined Journey to Remission and a Renewed Sense of Faith
10. Particulate Emission from Natural Gas Burning Home Appliances Is Assessed in Environmental Engineering Science Journal
11. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth ... country gathered at the La Valencia Hotel in San Diego, California to discuss ... named the year’s most outstanding franchise, walking away with the coveted David Wright ...
(Date:2/5/2016)... SARASOTA, Fla., (PRWEB) , ... February 05, 2016 , ... ... appetizing recipes just in time for this weekend’s Big Game. Take the stress out ... ingredients that will keep your guests happy at every stage of the game. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that should ... event they are experiencing an illness. Migraines are a severe form of a headache ... migraines would not wish the pain on their worst enemy, the feeling can last ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... Feb. 4, 2016 Worldwide Radiology Oncology ... growth as next generation systems provide a way ... for cancer surgery. New systems pinpoint the delivery ... has been such a problem previously, limiting the ... robots take cancer surgery far beyond what has ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  SciClone ... today announced it has entered into a settlement ... Commission (SEC) fully resolving the SEC,s investigation into ... (FCPA).  Under the terms of the settlement agreement, ... $12.8 million, including disgorgement, pre-judgment interest and a ...
Breaking Medicine Technology: